The early detection of bronchiectasis (BE) could be crucial to provide adequate treatment and to improve and control patients’ respiratory symptoms and quality of life in Type 2 severe asthma (T2-SA) patients. The disease condition has a causative role in the development of a serious lung condition that can lead to respiratory or heart failure.

A prospective observational multicentre study conducted on 113 T2-SA (Type 2 Severe Asthma) patients found that almost 45 percent of the T2SA patients had bronchiectasis as well, which was confirmed with a chest HRCT. The researchers  pointed out that BE associated with T2SA might cause exacerbations in asthma patients and that early detection is necessary for appropriate treatment. The study was published in the Journal of Asthma and Allergy yesterday (30th November).